Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance (INSPEAR)
Hervé M. Richet*
, Jasmine Mohammed*, L. Clifford McDonald†, William R. Jarvis*, and INSPEAR
, Jasmine Mohammed*, L. Clifford McDonald†, William R. Jarvis*, and INSPEAR
Table 1
Early warning system: global sentinel events
| Microorganism | Resistance |
|---|---|
| Streptococcus spp. | Penicillinase, gentamicin, glycopeptides, fluoroquinolones |
| S. pneumoniae | Vancomycin, third-generation cephalosporins, new fluoroquinolones (gemifloxacine, grepafloxacin, levofloxacin, trovafloxacin) |
| Staphylococcus spp. | Glycopeptides (high level) |
| Enterobacteriaceae | Carbapenemase |
| Neisseria meningitidis | Penicillinase, chloramphenicol, cephalosporins, fluoroquinolones |
| Acinetobacter baumannii | Carbapenemase |
| Salmonella typhi | Third-generation cephalosporins, fluoroquinolones |
| Haemophilus influenzae | Cephalosporins |
| Brucella spp. | Tetracycline, rifampin, streptomycin |
| Clostridium difficile | Glycopeptides |
| Clostridium perfringens | Penicillinase |
1D. Pittet, D.F. Brown, A.G. Dean, S. Gordon, I.M. Gould, M. Gubina, P. Heczko, M. Pana, J. Schindler, M.J. Struelens, F. Tenover, J. Vuopio-Varkila, A. Widmer, W. Witte.
Page created: May 10, 2011
Page updated: May 10, 2011
Page reviewed: May 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.